Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Market Cap	1.74B +8.0%
Revenue (ttm)	321.95M -16.3%
Net Income	25.26M +17.7%
EPS	2.29 +17.5%
Shares Out	11.02M
PE Ratio	68.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	613
Average Volume	1,103
Open	161.00
Previous Close	161.00
Day's Range	157.00 - 164.40
52-Week Range	129.11 - 290.78
Beta	0.53
RSI	45.55
Earnings Date	May 18, 2026

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2012
• Employees: 70
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ARVEE

Financial Performance

In fiscal year 2026, NSE:ARVEE's revenue was 321.95 million, a decrease of -16.35% compared to the previous year's 384.87 million. Earnings were 25.26 million, an increase of 17.65%.